The authors have no funding, financial relationships, or conflicts of interest to disclose.
Cranial Base
Angiogenesis in vestibular schwannomas: Expression of extracellular matrix factors MMP-2, MMP-9, and TIMP-1†
Article first published online: 26 JAN 2010
DOI: 10.1002/lary.20834
Copyright © 2010 The American Laryngological, Rhinological, and Otological Society, Inc.
Additional Information
How to Cite
Møller, M. N., Werther, K., Nalla, A., Stangerup, S.-E., Thomsen, J., Bøg-Hansen, T. C., Nielsen, H. J. and Cayé-Thomasen, P. (2010), Angiogenesis in vestibular schwannomas: Expression of extracellular matrix factors MMP-2, MMP-9, and TIMP-1. The Laryngoscope, 120: 657–662. doi: 10.1002/lary.20834
- †
Publication History
- Issue published online: 22 MAR 2010
- Article first published online: 26 JAN 2010
- Accepted manuscript online: 26 JAN 2010 12:00AM EST
- Manuscript Accepted: 8 DEC 2009
- Abstract
- Article
- References
- Cited By
Keywords:
- Acoustic neuroma;
- matrix metalloproteinase-2;
- matrix metalloproteinase-9;
- tissue inhibitors of metalloproteinase-1;
- vascular endothelial growth factor;
- receptor;
- homogenates
Abstract
Objectives/Hypothesis:
Vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) are potent mediators of tumor angiogenesis. It has been demonstrated that vestibular schwannoma VEGF expression correlates with tumor growth pattern, whereas knowledge on the expression of MMPs is lacking. This study targets the angiogenic process by investigation of tumor expression of MMP-2, MMP-9, and tissue inhibitors of metalloproteinase (TIMP)-1. A possible correlation with gender, patient age, symptom duration, tumor size, and the absolute and relative growth rate is explored.
Study Design:
Prospective vestibular schwannoma tissue sampling for ELISA and immunohistochemical determination of MMP-2, MMP-9 and TIMP-1.
Methods:
Thirty-four patients with a sporadic, noncystic, vestibular schwannoma were selected prospectively. Repeated, preoperative magnetic resonance imaging determined the tumor growth pattern. Following translabyrinthine resection, an enzyme-linked immunosorbent assay was used for determination of the MMP-2, MMP-9, and TIMP-1 concentration in tumor sample homogenates. Immunohistochemical labeling was performed in 12 randomly selected tumors.
Results:
All tumor homogenates expressed measurable MMP-9, MMP-2, and TIMP-1. Immunolabeling localized MMP-9 expression to the tumor cells, whereas MMP-2 and TIMP-1 was found interstitially. A significant correlation existed between the concentration MMP-9 and absolute tumor growth rate, whereas a weak correlation occurred for the relative growth rate.
Conclusions:
Vestibular schwannomas express MMP-2, MMP-9, and TIMP-1 and the tumor concentration of MMP-9 correlates with absolute tumor growth rate, but not with age, gender, symptom duration, or preoperative tumor size. No correlations existed between any clinical parameter and MMP-2 or TIMP-1 expression. We conclude that MMP-9 appears to be involved in the growth of vestibular schwannomas. Laryngoscope, 2010

1531-4995/asset/LARY_left.gif?v=1&s=090428e024b2aa383baac1dfc1a89ff3d0fcc25d)
1531-4995/asset/LARY_right.gif?v=1&s=a440e2f7fdbd0a386529e525815a128daeeea27b)
1531-4995/asset/cover.gif?v=1&s=ac9e987508d442acd12556b278c60cf12b627a2e)